Collaboration is crucial when it comes to developing drug therapies for rare diseases. Nan Doyle, Adam Sherman, and Onno Faber discuss how a patient is able to be involved in every step of the process, and what pharmaceutical companies and researchers can do to form trust in these collaborative partnerships.
Stay Connected
Sign up for updates straight to your inbox.